News und Analysen
Agilent Early Career Professor Award Presented to Jason H. Yang
Agilent Technologies Inc. (NYSE: A) today announced that Jason H. Yang, Ph.D., has received the 2021 Agilent Early Career Professor Award. Dr. Yang is an assistant professor of Microbiology
PFIZER REPORTS SECOND-QUARTER 2021 RESULTS
Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3) driven by its updated expectations for contributions
Clinical Utility of ALK Fusion Detection by Liquid Biopsy
Agilent Technologies Inc. (NYSE: A) today announced the publication of a paper in the journal Lung Cancer, titled "Clinical Utility of Next-Generation Sequencing-Based ctDNA Testing for Common and
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. These doses
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection.
“This acquisition is procompetitive, and we have
Agilent Technologies Celebrates More than 20 Years of Sustainable Progress
Agilent Technologies, Inc. (NYSE: A) today issued its 21st annual Corporate Social Responsibility (CSR) report. The report highlights the company’s progress in critical environmental, social and
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has notified the company that it will not meet the Prescription Drug User Fee Act (PDUFA) goal dates for the
Agilent to Webcast Third-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release third-quarter fiscal year 2021 financial results after the stock market closes on Tuesday, August 17. The company will host a live webcast of its
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African
Agilent PD-L1 IHC 22C3 pharmDx Expands CE-IVD mark in Non-small Cell Lung Cancer (NSCLC)
Agilent Technologies Inc. (NYSE: A) today announced that the company’s PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the
Agilent Announces Optimized and Verified Method for Testing Over 100 PFAS Compounds
Agilent Technologies Inc. (NYSE: A) today announced the availability of an optimized and verified eMethod for PFAS Analysis in Water by LC/TQ for testing per- and polyfluoroalkyl substances (PFAS)
Pfizer Announces New Investor Relations Leader
Pfizer Inc. (NYSE: PFE) today announced that Christopher Stevo has joined the company as Senior Vice President and Chief Investor Relations Officer, reporting to Chief Corporate Affairs Officer
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021.
On the same day, at 2:00 pm Pacific
Louisville Nonprofits Receive $1.7 Million through The Humana Foundation’s Community Partners Program
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, is awarding $1.7 million to nonprofit organizations in Louisville as part of its ongoing Community
Humana Hiring up to 200 Virtual, Seasonal Positions in San Antonio
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced it is looking to hire up to 200 virtual, seasonal Enrollment Representatives in and around San Antonio.
Humana’s
Montefiore Health System and Humana Sign Multi-Year Agreement Offering In-Network Coverage for Medicare Advantage Members
Montefiore Health System, one of New York’s premier academic health systems, and leading health and well-being company Humana Inc. (NYSE: HUM), have signed a multi-year agreement that gives Humana
Humana Hiring up to 200 Seasonal Positions in Louisville
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced it is looking to hire up to 200 seasonal Enrollment Representatives in and around Louisville.
Humana’s Medicare
Humana Ranked No. 1 Among Health Insurers for Customer Experience
Humana ranked No. 1 among Health Insurers for customer experience (CX) quality in Forrester’s proprietary 2021 US CX Index™ survey. The ranking was based on responses from more than 85,000 US
TA Instruments Helps Laboratories Automate Thermal Analysis Workflows with New TRIOS AutoPilot Software
Waters Corporation (NYSE:WAT) today introduced TRIOS AutoPilot software from its TA Instruments Division for its thermal analyzer product line. The software helps laboratory staff using TA’s
Resolution Bioscience (a part of Agilent) Investigated Acquired Resistance to KRAS G12C Inhibition
Agilent Technologies Inc. (NYSE: A) today announced the publication of a study carried out in partnership with Resolution Bioscience (a part of Agilent) and Dana-Farber Cancer Institute. The paper
Waters to Help Accelerate Biologics Production Through Research Collaboration With Singapore’s Bioprocessing Technology Institute
Waters Corporation (NYSE:WAT) today announced an expansion of its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology
Waters Corporation Appoints Wei Jiang to Board of Directors
Waters Corporation (NYSE: WAT) today announced the appointment of Wei Jiang to its Board of Directors, effective July 14, 2021. Mr. Jiang currently serves as Executive Vice President and President
Pfizer Declares Third-Quarter 2021 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent third-quarter 2021 dividend on the company’s common stock, payable September 7, 2021, to holders of the Common
Humana Expanding its Commitment to Improving Physical and Mental Health Across North Carolina
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced it is expanding its commitment to the health and well-being of North Carolinians by more than doubling the number of
First Participant Dosed in Pfizer’s Pivotal Phase 3 TALAPRO-3 Combination Study of Talazoparib and Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in TALAPRO-3, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial. The study will